Importance of Communication Between Producers and Consumers of Publicly Available Experimental Data
Open Access
- 15 February 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 97 (4), 310-314
- https://doi.org/10.1093/jnci/dji053
Abstract
The application of mass spectrometry to discover new cancer biomarkers is in its infancy. Many of these new markers are low-abundance proteins that exist as fragments associated with carrier proteins. Although reproducibility is key to the use of mass spectrometry for ion fingerprint analysis, the scientific community has yet to establish a common platform or standardized operating procedures that are necessary for intra- and inter-laboratory comparison. In an effort to assist others who are perfecting mass spectrometry platforms for profiling, ongoing experimental data were posted for public consumption. An unintended consequence of unrestricted access to experimental data is the risk of inappropriate conclusions drawn and publicly disseminated that could have been avoided by communication between the producers and consumers of the data. Such disputes, however, should not divert us from the validation of this promising new approach.Keywords
This publication has 22 references indexed in Scilit:
- Signal in Noise: Evaluating Reported Reproducibility of Serum Proteomic Tests for Ovarian CancerJNCI Journal of the National Cancer Institute, 2005
- Enhancement of Sensitivity and Resolution of Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometric Records for Serum Peptides Using Time-Series Analysis TechniquesClinical Chemistry, 2005
- SERUM PROTEOMIC PROFILING CAN DISCRIMINATE PROSTATE CANCER FROM BENIGN PROSTATES IN MEN WITH TOTAL PROSTATE SPECIFIC ANTIGEN LEVELS BETWEEN 2.5 AND 15.0 NG/MLJournal of Urology, 2004
- Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian CancerCancer Research, 2004
- Lessons from Kitty Hawk: From feasibility to routine clinical use for the field of proteomic pattern diagnosticsProteomics, 2004
- Serum Protein Profiles to Identify Head and Neck CancerClinical Cancer Research, 2004
- Detection of cancer-specific markers amid massive mass spectral dataProceedings of the National Academy of Sciences, 2003
- Use of proteomic patterns in serum to identify ovarian cancerThe Lancet, 2002
- Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissuesNature Medicine, 2001
- Rapid Identification of Intact Whole Bacteria Based on Spectral Patterns using Matrix-assisted Laser Desorption/Ionization with Time-of-flight Mass SpectrometryRapid Communications in Mass Spectrometry, 1996